Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Intended Use: For Laboratory Research Use Only Key Characteristics of Tirzepatide (50 mg) Dual incretin receptor-targeted peptide for metabolic research Designed to activate both GIP and GLP-1 receptors in controlled experimental models C20 fatty acid side-chain modification supports enhanced molecular stability and prolonged receptor interaction Amino acid substitutions increase resistance to enzymatic degradation High purity confirmed through HPLC and mass spectrometry Lyophilized form preserves structural integrity before reconstitution Ideal for in vitro studies and preclinical metabolic research models How Tirzepatide (50 mg) Supports Research Tirzepatide (50 mg) is used in laboratory experiments to study the dual activation of GIP and GLP-1 receptors
Our medical reviewers confirm this matches what we see in lab booking data: a high share of stool-test requests in our female panel come during the second half of the menstrual cycle
Groups that should avoid or seek clinician guidance first Pregnancy and breastfeeding: GHK-Cu has not been adequately studied in pregnancy or lactation
62 Alcohol When talking about alcohol, it is noteworthy that not all types of alcohol are the same
US$ 29.76
US$ 25.17
US$ 28.57
